Vaughan Nelson Investment Management’s Pediatrix Medical MD Stock Holding History

Vaughan Nelson Investment Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-938,140	Closed	-$65.1M	–	201
2017 Q1	$65.1M	Sell	938,140 -21,240	-2%	-$1.48M	0.76%	41
2016 Q4	$64M	Sell	959,380 -96,770	-9%	-$6.3M	0.75%	45
2016 Q3	$70M	Sell	1,056,150 -53,000	-5%	-$3.63M	0.83%	37
2016 Q2	$80.3M	Buy	+1,109,150	New	+$76.2M	1.02%	24

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Vaughan Nelson Investment Management's MD Position: Q2 2017 in Review

Vaughan Nelson Investment Management sold out of Pediatrix Medical (MD) in Q2 2017, closing a stake of 938,140 shares — an estimated $65.1M sold.

Vaughan Nelson Investment Management first reported a position in MD in Q2 2016 and held it in 4 quarters. The position peaked at $80.3M in Q2 2016. 332 funds tracked by Wall St. Rank hold MD as of Q2 2017.

Vaughan Nelson Investment Management reported no remaining Pediatrix Medical position as of Q2 2017 after selling out during the quarter.
Vaughan Nelson Investment Management sold 938,140 Pediatrix Medical shares in Q2 2017, an estimated $65.1M.
Vaughan Nelson Investment Management first reported a position in Pediatrix Medical in Q2 2016 and held it in 4 quarters.
Vaughan Nelson Investment Management's Pediatrix Medical position peaked at $80.3M in Q2 2016.
332 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2017.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2017, filed 17 Jul 2017.